Aim: To identify the influence of pancreatic stellate cell (PSCs) secretions on gene expression profiles of Min6 cells by whole transcriptome sequencing. Methods: Pancreatic stellate cells (PSCs) were isolated from C57BL6J mice and propagated in vitro to acquire the activated phenotype. Total RNA was isolated from monocultured (MC) and PSC cocultured (CC) Min6 cells to prepare cDNA libraries, which were subjected to whole transcriptome sequencing for identifying differential expression of β-cell transcription factors (Pdx-1, Rfx6 and NeuroD1) related to insulin gene transcription and GSIS related genes such as Glut2, Gck, Abcc8, Kcnj11 and L-type Ca How to cite this paper:
Introduction
The functioning of pancreatic β-cells, which perform a pivotal role in maintaining glucose homeostasis, is influenced by various factors including nutritional [1] [2] [3] , metabolic [4] [5] and hormonal factors [6] [7] [8] , as well as pancreatic inflammatory microenvironment [9] [10] [11] [12] . While islet functions are largely unruffled in healthy individuals, alterations in one or more of these factors cause considerable morbidity experienced in pancreatic disease that may be associated with fibrosis [13] [14] [15] , resulting from inflammatory cells and activation of pancreatic stellate cells (PSCs). Elevated levels of pancreatic proinflammatory cytokines such as IL-1β, TNF-α and IFN-γ encountered in pancreatic fibro-inflammatory disease conditions like chronic pancreatitis (CP) [16] , and pancreatic cancer (PC) [17] [18] [19] , and emanating from various sources including activated PSCs are known to contribute towards β-cell damage and impaired insulin secretion. Activated PSCs are also known to secrete IL-6 [20] [21], as well as growth factors such as Activin-A [22] , and Hepatocyte Growth Factor (HGF) [23] , which are known to promote Glucose Stimulated Insulin Secretion (GSIS) [24] - [29] from β-cells. In addition, the accumulation of PSCs in peri-islet regions and PSC infiltration [14] [15] [30] [31] into the islets of patients with CP and PC also suggest a probable role for PSCs in influencing β-cell function associated with pancreatic disease.
Recent studies with rodents involving coculture of activated PSCs with islets and with β cell lines indicated variable influence of PSCs on insulin secretory response of β-cells. Rat insulinoma cell lines (RINm-5F, INS-1) showed decreased insulin secretion [14] [32] when cocultured with PSCs or incubated with PSC conditioned medium. In yet another study, increased insulin secretory response associated with a decrease in total insulin content was reported when mouse islets were cocultured with PSCs [33] . Availability of adequate information regarding gene expression in β-cells in response to the presence of PSCs in coculture conditions, would resolve these observations and comprehensively elucidate the influence of PSCs on β-cell functions. In view of these considerations, the present study involving indirect coculture of Min6 cells with activated PSCs was aimed to 1) study the transcriptome profile alterations and the accompanying 2) expression of β-cell specific transcription factors and GSIS related genes in Min6 cells. 
Materials and Methods

Chemical
All the chemicals used in the experiments are obtained from Sigma unless otherwise mentioned.
Cells and Culture Conditions
Mouse insulinoma cells The quiescent phenotype of isolated PSCs was ascertained by appearance of lipid droplets within 6 -8 hours. These primary cells are subsequently passaged to obtain the activated phenotype of PSCs under in vitro conditions. All the indirect coculture experiments are conducted using activated PSCs of passage 3.
Indirect Coculture of PSCs with Min6 Cells
Min6 cells were subjected to indirect coculture with activated PSCs using transwell inserts with polycarbonate membrane (Himedia, India) having a pore size of 0.4 µm as per the method described earlier [14] 
Whole Transcriptome Sequencing
Total RNA was isolated from Min6 cells employing RNeasy kit (Qiagen, Germany) as per the manufacturer's protocol. Quantity and quality of the isolated RNA was assessed using Bioanalyzer 2100 (Agilent, Germany) and samples which showed RNA integrity number > 8 were used in this study. Whole transcriptome sequencing was performed on monocultured and PSC cocultured Min6 cells samples employing Ion Total RNA-Seq kit V2, including Ion RNA-Seq Core kit v2, Ion RNA-Seq Primer Set (Life technologies, USA). Briefly, 5 µg of total RNA was purified using RiboMinus™ Eukaryote System v2 Kit to obtain rRNA-depleted total RNA. RNA thus obtained was fragmented using RNase III for 10 minutes and purified using magnetic beads. Purified RNA was quantitated on Agilent Bioanalyzer using RNA 6000 Pico Kit which yielded fragments in the range of 100 -200 nucleotides. Whole transcriptome libraries were constructed by hybridizing and ligating the RNA and subjected to reverse transcription. The obtained cDNA was purified and amplified by polymerase chain reaction. The yield and size distribution of the amplified cDNA was assessed; barcoded pooled transcriptome libraries were sequenced on Proton Semiconductor Sequencer (Ion torrent, Life Technologies, USA). Whole transcriptome sequencing was performed using a single set of total RNA samples isolated from monocultured and PSC cocultured Min6 cells. Sequencing reads were assessed for quality and single-end mRNA reads were mapped onto Mouse genome (mm10) and analyzed using Partek Genomics Suite v6.6. BAM files were imported into the software; samples were assigned the respective attributes using categorical (Coculture Vs Monoculture) variables.
Gene Expression Studies
Validation of target gene expression by qRT-PCR Total RNA was isolated from both monocultured and PSC cocultured Min6 cells using TRIzol® reagent (Ambion®, Life Technologies, USA) as per the manufacturer's protocol. 1 µg of total RNA was used to synthesize the cDNA reaction using Superscript IV First-Strand Synthesis System (Invitrogen, Lithuania) in a total volume of 20 μL reaction setup. The prepared cDNA was used to validate the differential expression of β-cell specific and GSIS related genes that were identified in the discovery study, using the Power Sybr® green PCR Master Mix (Applied Biosystems, United Kingdom) on
Step One® Real Time PCR System (Applied Biosystems, Singapore). Forward and reverse primer sequences for the target genes used in this study are listed in expression was normalized to the expression levels of β-actin. The fold difference between the monoculture and coculture samples was calculated by using Pfaffl's 2 −ΔΔCt method and the obtained values were log2 transformed.
Glucose Stimulated Insulin Secretion
Glucose Stimulated Insulin Secretion (GSIS) from Min6 cells was examined as per the method described earlier [24] . Min6 cells were incubated in 
Measurement of Insulin Contents in Min6 Cells
Min6 cells were lysed in Radio Immuno Precipitation Assay (RIPA) buffer (Cell Signaling Technologies, USA) and incubated on ice for 5 minutes. The cell lysates were then briefly sonicated and centrifuged at 14,000 ×g for 10 minutes at 4˚C. The concentration of the total protein in these samples was measured using Bradford's method. The supernatants were collected and stored at −20˚C until further use to measure the total insulin content. Insulin was estimated using mouse insulin ELISA (Mercodia, Sweden) kit and OD was recorded at 450 nm on a microplate reader (BioRad Model 680, Japan). Insulin contents were normalized to total protein and expressed in terms of pmoles of insulin per mg protein.
Statistical Analysis
Probability (p) values between the MC and CC groups were calculated using Student's t-test using Microsoft Excel program. Data are represented as mean +/− SEM. p ≤ 0.05 is considered to be statistically significant.
Results
Whole Transcriptome Analysis Identifies Differentially Expressed Genes in Higher Passage Min6 Cells Cocultured with PSCs
The discovery set of cDNA libraries, with an average size of 248 and 269 bp length respectively, were prepared from Min6 cells cultured in presence or in absence of PSCs and subjected to whole transcriptome sequencing. These cDNA libraries generated ≈ 67 million reads with a mean length of 107 bp and 54% usable reads for MC higher passage Min6 cells and ≈58 million reads with 92 bp as mean length and 46% usable reads for CC samples. The usable reads obtained from the whole transcriptome sequencing were aligned separately on to the mouse mm10 reference genome, which identified 29610 transcripts during the analysis. Expression levels of the transcripts were normalized as reads per kilobase per million mapped reads (RPKM) to identify the differentially expressed genes. Of all the genes subjected to transcriptome analysis in the discovery set, important changes could be noted with regard to increased expression of β-cell specific genes such Ins1 ( 
qRT-PCR Validation Identifies Increased Expression of Ins1,
Rfx-6 and NeuroD1 Genes in PSC Cocultured Higher Passage Min6 Cells
Changes in the expression levels of β-cell related genes observed in the discovery (Figure 1(a) ).
PSCs Do Not Alter the Expression of GSIS Related Genes in Higher Passage Min6 Cells
As in case of β-cell related genes, changes in the expression levels of GSIS associated genes are also validated by qRT-PCR. Although the expression levels of (Figure 1(b) ), which was noticed to be upregulated by 1.2-fold in the discovery study. 
PSC Secretions Do Not Restore GSIS from Higher Passage Glucose Unresponsive Min6 Cells
GSIS response of Min6 cells at high passage (P53-64) was examined when they were cultured in presence or in absence of PSC secretions and the obtained results are depicted in Figure 2 (Figure 4 (a) & Figure  4(b) ).
Discussion
The In our study we employed Min6 cells of higher passage (P53-64) and examined their insulin secretory responses. These cells did not exhibit much change in their GSIS response either in monoculture or coculture. Such an observation may be ascribed to the reported inability of glucose unresponsive higher passage Min6 cells to high glucose challenge [41] [42] . This result also indicates the inability of PSC secretions to restore the lost ability of insulin secretion of higher passage Min6 cells to glucose challenge. In order to verify such an inference, we examined GSIS of lower passage Min6 cells (P11) that were cultured to higher passage (P53-64). Results of this experiment as shown in Figure  3 (a) demonstrated the ability of such cells not only to respond to glucose challenge but also confirmed that PSC secretions further enhance insulin release by Min6 cells. The ability of higher passage Min6 cells to respond to glucose challenge in presence of PSC secretions also denotes that the glucose responsive nature of Min6 cells is of key relevance for the PSCs to influence insulin secretory abilities of Min6 cells. It is apparent that results obtained upon in vitro studies might not reflect in vivo situation, more so under disease conditions. Extrapolating the results reported herein to a physiological context, we may infer that even though PSCs can innately influence insulin secretory abilities of β-cells, it is possible that such an ability might be diminished in pancreatic disease.
The nature of secretions made by PSCs has not been characterized in the present study. It is known that PSC secretions, including inflammatory cytokines and different growth factors, can not only influence the pancreatic milieu but Advances in Bioscience and Biotechnology also influence β-cell functions. Importantly, the nature of PSC secretions under in vivo disease conditions would largely determine their influence on β-cell functions. Despite these limitations, this is the first report on the influence of PSCs on transcriptome profiles as well as genes that are involved in the insulin synthesis and secretory pathway of higher passage Min6 cells. Further experiments including characterization of PSC secretome should yield important information about their influence on gene expression profiles and insulin secretory response from islet isolates obtained from diabetic conditions.
